Q4 2024 EPS Estimates for Cardinal Health, Inc. Lowered by Analyst (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Investment analysts at Leerink Partnrs lowered their Q4 2024 earnings estimates for shares of Cardinal Health in a note issued to investors on Thursday, May 2nd. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $1.75 for the quarter, down from their previous estimate of $1.79. Leerink Partnrs currently has a "Outperform" rating on the stock. The consensus estimate for Cardinal Health's current full-year earnings is $7.34 per share. Leerink Partnrs also issued estimates for Cardinal Health's Q1 2025 earnings at $1.72 EPS, Q2 2025 earnings at $1.82 EPS, Q3 2025 earnings at $2.10 EPS, FY2025 earnings at $7.60 EPS, FY2026 earnings at $8.41 EPS, FY2027 earnings at $9.22 EPS and FY2028 earnings at $10.05 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.13. The company had revenue of $54.90 billion for the quarter, compared to analysts' expectations of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The firm's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.74 EPS.

CAH has been the subject of a number of other research reports. StockNews.com upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Thursday. Robert W. Baird decreased their price target on Cardinal Health from $134.00 to $128.00 and set an "outperform" rating on the stock in a research note on Friday. Wells Fargo & Company dropped their price objective on Cardinal Health from $96.00 to $94.00 and set an "underweight" rating for the company in a research note on Monday, April 29th. Argus raised Cardinal Health from a "hold" rating to a "buy" rating in a report on Friday, February 9th. Finally, UBS Group upped their target price on Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a report on Monday, February 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $105.79.

Cardinal Health Stock Performance

NYSE:CAH traded down $0.32 during trading hours on Monday, hitting $98.59. The company's stock had a trading volume of 1,889,756 shares, compared to its average volume of 2,284,192. The company has a market capitalization of $24.01 billion, a PE ratio of 43.96, a PEG ratio of 1.01 and a beta of 0.71. Cardinal Health has a 52-week low of $80.90 and a 52-week high of $116.04. The business's 50-day moving average is $109.10 and its two-hundred day moving average is $105.17.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health's dividend payout ratio is presently 88.89%.

Institutional Investors Weigh In On Cardinal Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Aaron Wealth Advisors LLC grew its holdings in Cardinal Health by 1.2% in the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company's stock valued at $844,000 after buying an additional 97 shares during the period. Schechter Investment Advisors LLC increased its position in Cardinal Health by 4.1% during the fourth quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company's stock worth $250,000 after purchasing an additional 98 shares during the last quarter. J. W. Coons Advisors LLC raised its stake in Cardinal Health by 0.6% during the fourth quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company's stock worth $1,681,000 after purchasing an additional 100 shares during the period. Edmonds Duncan Registered Investment Advisors LLC boosted its holdings in shares of Cardinal Health by 5.0% in the 1st quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company's stock valued at $234,000 after purchasing an additional 100 shares during the last quarter. Finally, Cypress Capital Group grew its stake in shares of Cardinal Health by 0.7% during the 3rd quarter. Cypress Capital Group now owns 17,133 shares of the company's stock valued at $1,487,000 after buying an additional 111 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.